International Congress on Biotechnology and Food Sciences
  • Follow

Accepted Abstracts

Introducing the Sorush Cancer Treatment Protocol (SCTP)

Sorush Miknamian*
Liberty University, USA

Citation: Miknamian S (2020) Introducing the Sorush Cancer Treatment Protocol (SCTP). SciTech Management Sciences 2020

Received: August 24, 2020         Accepted: August 28, 2020         Published: August 28, 2020

Abstract

This research introduces Sorush Cancer Treatment Protocol (SCTP) based on successful cancer treatment methodology which has done by Dr. Somayeh Zaminpira and Dr. Sorush Niknamian in 54 cancer patients in Violet Cancer Institute (VCI), Combining Specific Ketogenic Diet (SKD) - which has 80% saturated fat, 15% Protein with the lowest glutamine and 5% complex-high fibre carbohydrate- and intravenous ozone therapy which has had marvelous results in the treatment of several cancers in human models. The aim of this protocol is to weaken and starve cancer cells, decreasing acidity, increasing the immune system response, decreasing the possibility of metastasis and decreasing the cachexia without any serious side effects in cancer patients. This protocol introduces mega vitamins and minerals plus several supplements based on some tried and true protocols mainly the Budwig and Bill Henderson Protocol (BHP) with serious revisions. The BHP incorporates principal components of the Budwig Diet which was developed in the early 1950s by German chemist Dr. Johanna Budwig (1908–2003). Budwig’s theory is based upon the work of Otto Warburg (1883–1970). Warburg was an earlier Nobel Prize Laureate (1931) for the discovery of the nature and action of the respiratory enzyme, the first of the so-called yellow enzymes, or flavoproteins. Warburg’s scientific efforts produced a large body of work and publications in highly respected journals such as Science (1928, 1956). According to Budwig, Warburg theorized that cellular respiration, like many chemical reactions, was dependent upon substrate availability, specifically a sulphydryl group and an unknown saturated fatty acid, which he failed to identify. According to Dr. S. Zaminpira and Dr. S. Niknamian, Cancer is an Evolutionary Metabolic disease (EMHC) and the main cause of cancer is the Butterfly Effect inside normal cells as a result of increasing the amounts of Reactive Oxygen Species (ROS).

KEYWORDS: 
SCTP; SKD; BHP; Budwig protocol; EMHC; ROS; Ozone therapy; HBO2T; Cancer treatment, Cancer prevention.